Comparative Heme Metabolism in Divergent Eukaryotes
Comparative Heme Metabolism in Divergent Eukaryotes
批准号:
10615301
负责人:
Paul A Sigala
金额:
$5.59万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-01 至 2024-05-31
关键词:
ApoptosisBindingBiochemicalBiogenesisBiologicalCellsChemistryComparative StudyDefectElectron TransportEnzymesErythrocytesEukaryotaEukaryotic CellGoalsHemeHumanInvadedMediatingMetabolismMitochondriaMitochondrial MatrixMolecularOxidation-ReductionParasitesPeroxidasesPlasmodiumPlayProductionPropertyResearchRespirationRoleSignal TransductionSiteStructureTestingToxic effectWorkcofactorcomparativecytochrome cemerging pathogenheme-binding proteinhuman diseasehuman pathogeninsightmitochondrial dysfunctionpathogenpathogenic microbeprogramsthioetherthree dimensional structuretrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Heme is an ancient biological cofactor that plays critical roles in mitochondrial redox chemistry, energy
production, and signaling in all eukaryotic cells from humans to microbial pathogens. Despite functional
similarities in their reliance on heme, divergent eukaryotes have evolved distinct molecular adaptations that tune
heme metabolism to particular cellular demands. Comparing and contrasting key features of mitochondrial heme
metabolism can thus reveal general principles in heme trafficking and utilization, as well as unveil unique
adaptations that highlight the evolutionary diversity among eukaryotes. Elucidating these general principles will
increase understanding of heme-related mitochondrial dysfunctions that underpin major human diseases.
Understanding of functional differences in heme metabolism can be exploited to develop new pathogen-specific
therapies that avoid human toxicity. In this proposal, we lay out a long-term goal of our research program
to deeply understand key biochemical properties and mechanisms of mitochondrial heme metabolism
in humans and a major human pathogen. In pursuing this goal over the next five years, we will focus our
studies on understanding the molecular mechanisms of biogenesis and function of cytochrome c, a critical and
tractable heme-binding protein with major unresolved mechanistic features that exemplifies key features of
mitochondrial heme metabolism and its conservation as well as diversity between eukaryotes. Cytochrome c has
a conserved essential function in the mitochondrial electron transport chain (ETC) but also plays an important,
separate role as a peroxidase that signals the onset of apoptosis. The molecular features of cytochrome c that
underpin its functional transition from ETC to peroxidase activity remain sparsely defined. Cytochrome c is
distinguished from other heme-binding proteins by its use of a conserved CXXCH sequence motif to covalently
bind heme via stable thioether bonds. This covalent attachment requires the mitochondrial intermembrane space
(IMS) enzyme, holo cytochrome c synthase (HCCS). Although HCCS function is fundamental to all eukaryotic
respiration, the structure of HCCS is unknown and thus molecular insight into its mechanism of attaching heme
to cytochrome c is lacking. Furthermore, it remains unknown how heme is trafficked to HCCS in the IMS from its
site of synthesis within the mitochondrial matrix. We propose comparative studies between human cells and
Plasmodium parasites that invade heme-rich human erythrocytes to tackle the following key challenges: 1) to
define the molecular features of cytochrome c that mediate its transition between ETC and peroxidase activities;
2) to elucidate the three-dimensional structure of HCCS and unravel its molecular mechanism of heme
attachment to cytochrome c; and 3) to determine the mechanism of heme acquisition by HCCS. This work will
advance fundamental understanding of mitochondrial heme metabolism in humans and a critical human
pathogen and provide a platform for longer-term integrative studies of heme metabolism that will test and extend
the lessons learned from our initial focus on cytochrome c.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comparative Heme Metabolism in Divergent Eukaryotes
-
批准号:9982387
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2019
-
负责人:Paul A Sigala
-
依托单位:
Comparative Heme Metabolism in Divergent Eukaryotes
-
批准号:10618985
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2019
-
负责人:Paul A Sigala
-
依托单位:
Comparative Heme Metabolism in Divergent Eukaryotes
-
批准号:10159278
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2019
-
负责人:Paul A Sigala
-
依托单位:
Comparative Heme Metabolism in Divergent Eukaryotes
-
批准号:10728411
-
项目类别:
-
资助金额:$3.26万
-
财政年份:2019
-
负责人:Paul A Sigala
-
依托单位:
Comparative Heme Metabolism in Divergent Eukaryotes
-
批准号:10404110
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2019
-
负责人:Paul A Sigala
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: